955 PRECLINICAL POTENCY, PHARMACOKINETIC AND ADME CHARACTERIZATION OF ABT-333, A NOVEL NON-NUCLEOSIDE HCV POLYMERASE INHIBITOR
暂无分享,去创建一个
A. Molla | D. Beno | C. Flentge | W. Kati | D. Hutchinson | Yaya Liu | R. Wagner | Y. Lau | J. Beyer | C. Maring | G. Koev | J. Fischer | Rubina Mondal | J. Shen | S. Vaidyanathan | B. Lim | Yi Gao | J. Shen